RATIONALE
In spite of new point-of-care and laboratory diagnostic
tools as well as new antibacterial agents being
available, viral, bacterial and fungal infections still cause
unacceptably high mortality rates in these polymorbid
patient populations.
Back in 2010, when the first ATCIP took place in Lugano, the
infectious diseases specialists were fighting an increasing
number of viral, bacterial and fungal pathogens that made
the treatment of immunocompromised and critically ill
patients a daunting task.
The situation has not changed
substantially: although some infectious agents such as
the hepatitis C virus can now be successfully treated,
new opportunistic pathogens are increasingly reported
to infect transplantation recipients as well as oncology
and ICU patients. Resistance in viral, bacterial and fungal
pathogens is also increasing and makes the work by
the treating physicians or ICU and ID specialists more
difficult. There is a need for a concerted, multidisciplinary
approach towards the treatment of such infections:
multicentre, international, well-orchestrated efforts
should be started to develop clear and comprehensive
guidelines on the prevention, diagnosis, treatment and
evaluation of therapeutic success.
The aim of ATCIP 2020 is to provide practical, updated
information on the management of infectious diseases
and the most appropriate antimicrobial therapy in
immunocompromised and critically ill patients.
Brief talks given by international experts will provide
insight into research and therapy of infectious diseases
during plenary sessions and an interactive session. New
rapid diagnostic tools and their utility for the clinician
will be discussed. Infectious complications in transplant
patients and the corresponding therapeutic approaches
will be reviewed in a dedicated session, as will infections
related to the use of immunosuppressive agents in
oncology patients. New therapeutic approaches to treat
ventilator-associated pneumonia and infections after
abdominal surgery and recent treatment approaches for
HIV will be the theme of dedicated sessions. Advances in
the diagnosis of fungal pathogens, methods to tackle the
occurrence of invasive aspergillosis in the ICU, and new
treatment options against known and emerging invasive
fungal diseases will be discussed. A poster session will
allow participants to exchange information and to discuss
common problems.
OBJECTIVES
At the end of the congress, the participants should be able to approach the most common issues and controversies related to difficult-to-treat infectious diseases in immunocompromised and critically ill patients, and have gathered not only theoretical but also real-life experience to be translated into daily clinical practice.
WHO SHOULD ATTEND
Infectious disease and intensive care specialists,
oncologists and haemato-oncologists, transplant
specialists, clinical microbiologists, as well as other
health professionals involved in the care of critically ill
and immunocompromised patients.
SCIENTIFIC COMMITTEE
ENOS BERNASCONI, MD Lugano, CH
LUIGIA ELZI, MD
Locarno, CH
CHRISTIAN GARZONI, MD Lugano, CH
PAOLO GROSSI, MD
Varese, IT
OSCAR MARCHETTI, MD
Morges and Lausanne, CH
GLADYS MARTINETTI-LUCCHINI, PhD Bellinzona, CH
ORLANDO PETRINI, PhD
Lugano, CH
THU NOVEMBER 19TH, 2020
09.15
WELCOME, INTRODUCTION
FUNGINOS SYMPOSIUM: FUNGAL INFECTIONS
Chairs: PIERRE-YVES BOCHUD, Lausanne, Switzerland
NINA KHANNA Basel, Switzerland
09.30
Introduction
09.40
Novel diagnostics in mycology
FRÉDÉRIC LAMOTH, Lausanne, Switzerland
10.10
Aspergillus in the ICU (IA and viral infections)
BART RIJNDERS, Rotterdam, The Netherlands
10.40
Emerging fungal infections
FRÉDÉRIC LAMOTH, Lausanne, Switzerland
11.10
New antifungals
DIONYSOS NEOFYTOS, Geneva, Switzerland
11.40
GILEAD SPONSORED SYMPOSIUM
(with lunch bag)
The antifungal controversy: is therapeutic drug monitoring essential for success in aspergillosis?
12.40
COFFEE BREAK
SESSION I: MICROBIOLOGICAL DIAGNOSTICS
Chairs: ORLANDO PETRINI, Lugano, Switzerland – GLADYS MARTINET, Bellinzona, Switzerland
13.00
Multiplex PCR for the clinician: Advantages and
pitfalls
ADRIAN EGLI, Basel, Switzerland
13.30
Rapid diagnosis of candidaemia in the ICU:
mission possible?
MAURIZIO SANGUINETTI, Rome, Italy
14.00
Q&A - Discussion
14.30
COFFEE BREAK
SESSION II: NEWS IN HIV MEDICINE
(long-acting, eradication, vaccines)
Chairs: LUIGIA ELZI, Locarno, Switzerland – PAOLO GROSSI, Varese, Italy
14.45
Pre-exposure prophylaxis: standard and
new approaches
BENJAMIN HAMPEL, Zurich, Switzerland
15.15
HIV Therapy 2020
HANSJAKOB FURRER (TBC)
15.45
ViiV SPONSORED Lecture:
“The future of HIV therapy”
16.30
COFFEE BREAK
SESSION III: SEVERE BACTERIAL INFECTIONS IN THE
CRITICALLY ILL: NEW THERAPEUTIC APPROACHES
Chairs: PAOLO MERLANI Lugano, Switzerland TBC -
ANDREA DE GASPERI, Milan, Italy
17.00
Ventilator-associated pneumonia
JÉRÔME PUGIN, Geneva, Switzerland
17.30
Infections after abdominal surgery
GABRIELE SGANGA, Rome, Italy
18.00
Q&A - Discussion
18.30
CONCLUDING REMARKS
FRI NOVEMBER 20TH, 2020
SESSION IV: ONCOLOGY IN THE ERA OF BIOLOGICAL
IMMUNOSUPPRESSION: INFLAMMATIONS OR
INFECTIONS?
Chairs: CHRISTIAN GARZONI, Lugano, Switzerland TBC
08.00
Infectious complications after targeted
oncologic treatment with small molecule
inhibitors
MATHIAS KOCHANEK, Cologne, Germany
08.30
Radiological findings after targeted oncologic
treatment with small molecule inhibitors
GIANLUCA ARGENTIERI, Lugano, Switzerland
09.00
Neutropenic fever: treatment and assessment
of response
MALGORZATA MIKULSKA, Genova, Italy
09.30
The virome of transplant recipients
LAURENT KAISER, Geneva, Switzerland
10.00
Q&A - Discussion
10.30
COFFEE BREAK
11.00
PFIZER SPONSORED SYMPOSIUM
“Future directions in difficult to treat
Gram- infections”
12.00
COFFEE BREAK
12.15
MSD SPONSORED SYMPOSIUM
(with lunch bag)
STCS SYMPOSIUM: INFECTIONS IN TRANSPLANTED
PATIENTS
in collaboration with STCS
Chairs: MANUEL ORIOL, Lausanne, Switzerland - CHRISTIAN GARZONI, Lugano, Switzerland
13.00
Update and clinical implications of T-Cell
therapies for viral and fungal infection
NINA KHANNA, Basel, Switzerland
13.30
Microbiota and transplantation: quo vadis?
CHRISTIAN VAN DELDEN, Geneva, Switzerland
14.00
Donor-derived infection in SOT recipients:
emerging issues
PAOLO GROSSI, Varese, Italy
14.30
Q&A - Discussion
15.00
COFFEE BREAK
SESSION V: INTERACTIVE CASES
Chairs: ENOS BERNASCONI, Lugano, Switzerland TBC
15.30
6 cases, 20 minutes each
17.30
CONCLUDING REMARKS
REGISTRATION
Full Congress Fees
Before
31
Oct 2020
Before
16
Nov 2020
After 16
Nov and onsite 2020
Physicians, PhD, other academics
250.00 CHF
330.00 CHF
350.00 CHF
Nurses
150.00 CHF
230.00 CHF
250.00 CHF
Resident Physicians, Postdoctoral students †
150.00 CHF
160.00 CHF
180.00 CHF
Students *
150.00 CHF
160.00 CHF
180.00 CHF
Fees include VAT (7.7 %)
† Residents (holding an M.D. degree and practicing medicine in a hospital or clinic under the direct or indirect supervision of an attending physician) and postdoctoral students should produce a certification by their supervisors at the time of getting their congress material on site.
* Students (any school) should provide proof of enrolment (Student ID or a corresponding document) at the time of getting their congress material on site.
Registration Fee includes
- Participation in the conference
- Access to the Exhibition Area
- Conference kit
- Lunches
- Coffee breaks
- Certificate of attendance
Please note:
Accommodation and participation to the Social Dinner are available but not included in the Registration Fee.
How to register
Click on the following button
Payment method:
Credit Card
REGISTER NOWConfirmation of registration
The Organizing Secretary will send you the final confirmation.
Cancellation and Refunds
Cancellations will be refunded as follow:
Before 30th September 2020
50% of the amount paid (minus transaction fees)
After 30th September 2020 - No refund
All refunds will be paid after the conference.
Please note:
Aware of the ongoing global health emergency, we inform you that we will be constantly monitoring the
Covid-19 situation. According to the current dispositions the Event can be confirmed on site, but in case of
cancellation we will guarantee the full reimbursement of your congress fee.
Venue
Palazzo dei Congressi
Piazza Indipendenza, 4
6900 Lugano
How to reach us
Lugano is extremely easy to reach by public (railroad or Lugano Airport) or private transportation (A2 motorway).
The Milano-Malpensa International Airport is located at about 60 Km from Lugano and is conveniently served by a Shuttle Bus.
The Palazzo dei Congressi is located in the city centre, at walking distance from the Main Station and from the financial and recreational infrastructures, the Civic Park and the lake.
Directions (A2 motorway)
-
take exit 50-Lugano Sud toward Viale Giuseppe Cattori
-
keep left onto Viale Giuseppe Cattori
-
turn left onto Riva Paradiso
-
keep following the lake (Riva Caccia, Riva Vela and Riva Albertolli)
-
continue onto Piazza dei Congressi